Literature DB >> 15962332

Exercise training in mitochondrial myopathy: a randomized controlled trial.

Pilar Cejudo1, Juan Bautista, Teodoro Montemayor, Rafael Villagómez, Luis Jiménez, Francisco Ortega, Yolanda Campos, Hildegard Sánchez, Joaquín Arenas.   

Abstract

Patients with mitochondrial myopathies (MM) usually suffer from exercise intolerance due to their impaired oxidative capacity and physical deconditioning. We evaluated the effects of a 12-week supervised randomized rehabilitation program involving endurance training in patients with MM. Twenty MM patients were assigned to a training or control group. For three nonconsecutive days each week, patients combined cycle exercise at 70% of their peak work rate with three upper-body weight-lifting exercises performed at 50% of maximum capacity. Training increased maximal oxygen uptake (28.5%), work output (15.5%), and minute ventilation (40%), endurance performance (62%), walking distance in shuttle walking test (+95 m), and peripheral muscle strength (32%-62%), and improved Nottingham Health Profile scores (21.47%) and clinical symptoms. Control MM patients did not change from baseline. Results show that our exercise program is an adequate training strategy for patients with mitochondrial myopathy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15962332     DOI: 10.1002/mus.20368

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  22 in total

Review 1.  Therapeutic Approaches to Treat Mitochondrial Diseases: "One-Size-Fits-All" and "Precision Medicine" Strategies.

Authors:  Emanuela Bottani; Costanza Lamperti; Alessandro Prigione; Valeria Tiranti; Nicola Persico; Dario Brunetti
Journal:  Pharmaceutics       Date:  2020-11-11       Impact factor: 6.321

Review 2.  Advances in primary mitochondrial myopathies.

Authors:  Isabella Peixoto de Barcelos; Valentina Emmanuele; Michio Hirano
Journal:  Curr Opin Neurol       Date:  2019-10       Impact factor: 5.710

Review 3.  Strength training and aerobic exercise training for muscle disease.

Authors:  Nicoline Bm Voet; Elly L van der Kooi; Baziel Gm van Engelen; Alexander Ch Geurts
Journal:  Cochrane Database Syst Rev       Date:  2019-12-06

4.  Endurance Exercise Training in Young Adults with Barth Syndrome: A Pilot Study.

Authors:  W Todd Cade; Dominic N Reeds; Linda R Peterson; Kathryn L Bohnert; Rachel A Tinius; Paul B Benni; Barry J Byrne; Carolyn L Taylor
Journal:  JIMD Rep       Date:  2016-06-11

5.  Reduction in bone mineral density in glycogenosis type III may be due to a mixed muscle and bone deficit.

Authors:  H R Mundy; J E Williams; P J Lee; M S Fewtrell
Journal:  J Inherit Metab Dis       Date:  2008-04-04       Impact factor: 4.982

6.  Safety and efficacy of omaveloxolone in patients with mitochondrial myopathy: MOTOR trial.

Authors:  Karen L Madsen; Astrid E Buch; Bruce H Cohen; Marni J Falk; Angela Goldsberry; Amy Goldstein; Amel Karaa; Mary K Koenig; Colleen C Muraresku; Colin Meyer; Megan O'Grady; Fernando Scaglia; Perry B Shieh; Jerry Vockley; Zarazuela Zolkipli-Cunningham; Ronald G Haller; John Vissing
Journal:  Neurology       Date:  2020-01-02       Impact factor: 9.910

Review 7.  Treatment for mitochondrial disorders.

Authors:  Gerald Pfeffer; Kari Majamaa; Douglass M Turnbull; David Thorburn; Patrick F Chinnery
Journal:  Cochrane Database Syst Rev       Date:  2012-04-18

Review 8.  Current and Emerging Clinical Treatment in Mitochondrial Disease.

Authors:  Rory J Tinker; Albert Z Lim; Renae J Stefanetti; Robert McFarland
Journal:  Mol Diagn Ther       Date:  2021-03-01       Impact factor: 4.074

Review 9.  New treatments for mitochondrial disease-no time to drop our standards.

Authors:  Gerald Pfeffer; Rita Horvath; Thomas Klopstock; Vamsi K Mootha; Anu Suomalainen; Saskia Koene; Michio Hirano; Massimo Zeviani; Laurence A Bindoff; Patrick Yu-Wai-Man; Michael Hanna; Valerio Carelli; Robert McFarland; Kari Majamaa; Douglas M Turnbull; Jan Smeitink; Patrick F Chinnery
Journal:  Nat Rev Neurol       Date:  2013-07-02       Impact factor: 42.937

Review 10.  Diagnosis and management of mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society.

Authors:  Sumit Parikh; Amy Goldstein; Mary Kay Koenig; Fernando Scaglia; Gregory M Enns; Russell Saneto; Irina Anselm; Bruce H Cohen; Marni J Falk; Carol Greene; Andrea L Gropman; Richard Haas; Michio Hirano; Phil Morgan; Katherine Sims; Mark Tarnopolsky; Johan L K Van Hove; Lynne Wolfe; Salvatore DiMauro
Journal:  Genet Med       Date:  2014-12-11       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.